NJ MPJE study guide
NJ MPJE · Work through your exam, one topic at a time.
The New Jersey Multistate Pharmacy Jurisprudence Examination (NJ MPJE) is the law-and-regulations half of New Jersey pharmacist licensure. NABP builds the exam around a nationally standardized jurisprudence blueprint and layers in New Jersey-specific statutes and Board of Pharmacy rules; the New Jersey Board of Pharmacy, within the Division of Consumer Affairs, requires it alongside the NAPLEX before issuing a license to practice pharmacy in the state. The NJ MPJE study guide has 10 sections and about 3,441 words.
01FDCA and Federal Prescription Requirements
The FDCA of 1938, as amended by the Durham-Humphrey Amendments of 1951, created the prescription/OTC divide. A drug not safe for self-medication without professional supervision carries the 'Rx only' legend and may be dispensed only on a prescription of a practitioner licensed by law to administer it.
348 words, about 2 min02Federal Controlled Substances Act
A pharmacy registers with DEA at each location and renews every three years. Schedule II stock is ordered on DEA Form 222 (or CSOS) under a power of attorney; Schedules III–V are ordered on invoices that become your receiving record.
372 words, about 2 min03New Jersey Pharmacy Practice Act and Board Regulations
The Board of Pharmacy, within the Division of Consumer Affairs, licenses each pharmacy location through a pharmacy permit and licenses pharmacists, registered pharmacy technicians, and pharmacy interns individually. The permit attaches to a specific owner at a specific address and is not transferable: a change of ownership or location requires a new application.
311 words, about 2 min04New Jersey Controlled Dangerous Substances Act
New Jersey schedules controlled dangerous substances under its own act, largely tracking the federal schedules but with state-specific listings and rulemaking authority. Prescribers and pharmacies must hold New Jersey CDS registration through the Division of Consumer Affairs in addition to a DEA registration - one does not substitute for the other.
361 words, about 2 min05Dispensing, Labeling, and Patient Counseling
Every dispensing event runs the same pipeline: receive and validate the prescription (prescriber authority, patient identity, drug, strength, dosage form, directions, quantity, date, refills), perform a prospective drug utilization review against the patient profile (allergies, interactions, duplication, dose, adherence), prepare and verify, label, counsel, and document. The pharmacist is responsible for the clinical review and the final check; support personnel may perform mechanical and clerical steps.
357 words, about 2 min06Drug Product Selection, Substitution, and Therapeutic Interchange
Drug product selection is the pharmacist's option to dispense a lower-cost therapeutically equivalent product in place of the prescribed brand. The safe frame is narrow: same active ingredient, same strength, same dosage form, and an FDA therapeutic-equivalence rating permitting interchange.
329 words, about 2 min07Compounding: Sterile and Non-Sterile Standards
A 503A pharmacy compounds for an identified patient based on a prescription or a prescriber's notation, uses bulk ingredients that appear on the FDA bulks list, and may not compound essentially a copy of a commercially available product. A 503B outsourcing facility compounds without patient-specific prescriptions, operates under cGMP, and reports adverse events; it is the only lawful route for anticipatory, office-use sterile batches at scale.
306 words, about 2 min08Patient Safety, Error Reporting, and the Prescription Monitoring Program
Pharmacies are expected to operate a continuous quality improvement program: a defined process for identifying, documenting, and analyzing medication errors and near misses, with corrective action that changes the system rather than blaming an individual. Look-alike/sound-alike drug selection, tall-man lettering, independent double checks for high-alert medications, workflow separation for confusing products, and error-trigger reports are the usual tools.
351 words, about 2 min09Immunizations, Collaborative Practice, and Expanded Scope
New Jersey authorizes pharmacists to administer vaccines to adults under a valid prescription, standing order, or protocol, subject to conditions: completion of an ACPE-accredited immunization training program, current CPR certification, documented competency, and appropriate handling and storage of the vaccine. Administration must be reported to the New Jersey Immunization Information System.
345 words, about 2 min10Pharmacy Operations: Records, Transfers, Recalls, and Business Practices
Prescription records must capture the original prescription, refills, the identity of the dispensing pharmacist, substitution data, counseling documentation, and any prescriber clarifications, and must be retrievable on request by an authorized inspector. Federal controlled substance records are kept two years and readily retrievable, with Schedule II separated; New Jersey imposes its own retention period for prescription records, so confirm the longer of the two rather than assuming federal minimums control.
361 words, about 2 min